Modern Meadow, Inc. is a pioneering biologically advanced materials company that harnesses the power of design and biology to reinvent materials such as biofabricated leather.
Subscribe to see Modern Meadow, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Modern Meadow, Inc. is a biotechnology company headquartered in Nutley, United States, founded in 2011. It has raised at least $180M across the 4 funding rounds on record, 3 of them with a disclosed amount. Its most recent funding round, Series C, raised $130M in April 2021. Xcout tracks 1 named person at Modern Meadow, Inc., including David Williamson (CEO, PhD).
As of 16 November 2026. Source: Xcout Intel.
At least $180M raised across the 4 rounds on record (3 with a disclosed amount). Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series C | $130M | 4 named | |
| Strategic Investment | Undisclosed | 1 named | |
| Series B | $40M | 2 named | |
| Series A | $10M | 1 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A funding-flow diagram of the 6 named investors across 4 rounds: who backed which round, who led it, and who came back for the next one.
Sign in to see it, or subscribe for the full funding history →
A few of Modern Meadow, Inc.'s closest competitors — see the full list of competitors and alternatives →
Qorium creates beautiful, premium, and authentic leather without compromise by utilizing cutting-edge science and collagen sheets to dramatically reduce the environmental impact of traditional leather production. Headquartered in Maastricht, Netherlands, the company partners with top tanneries and global brands to deliver finished leather goods.
Melodea is an Israeli biotechnology company that develops sustainable cellulose-based materials, including cellulose nanocrystals and barrier coatings derived from plant fibers. Its products are intended primarily for packaging and other industrial applications as alternatives to petroleum-based plastics and coatings.
Antheia, Inc. is an advanced biotechnology research and biosynthesis company headquartered in Menlo Park, California, delivering 21st-century pharmaceutical solutions.
Mango Materials is a biotechnology company that produces biodegradable polyhydroxyalkanoate (PHA) bioplastics using methane and other waste gases as feedstocks. Its materials are intended for manufacturers seeking compostable or biodegradable alternatives to conventional petroleum-based plastics.
Frontier Bio develops engineered human tissues and vascular grafts to address cardiovascular disease and eliminate the need for organ donors and animal testing. The company provides tissue-engineered blood vessels for vascular grafts and commercializes human-based tissue models and services for preclinical testing.
Truelastin Laboratories develops natural elastin biomaterials and product platforms for human health applications. The company serves the medical aesthetics and therapeutic sectors by creating tissue-engineered products and advanced drug delivery systems.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Modern Meadow, Inc.? Suggest a correction · Work at Modern Meadow, Inc.? Claim this profile
Post the link and the card appears automatically — each network fetches the image itself.